Bionest Partners is a global consulting firm focused on Pharma, Biotech, Medical Device and Diagnostics.

Read More

Orphans Should Live Alone

Read our latest article for In Vivo with advice for pharma interested in rare diseases.

 

Read More

Immuno-Oncology Brings New Opportunities for Developers of Targeted Cytotoxics

The time is right to partner with immunotherapy firms, and for immunotherapy firms similarly to collaborate with those makers of targeted agents.

 

Read More

Running the Risks of High Stakes Drug Development

What does the failure of BMS’s nivolumab in Phase 3 mean for developers of PD-L1 inhibitor’s?

 

Learn More

Update on the “Cancer Moonshot” 

A number of new developments in this White House-led program provide opportunities for the oncology industry.

 

Learn More

Not Quite What the Headlines Suggest: Some Comments on Drug Pricing Issues

Do we have a pricing problem or an insurance co-pay problem?

 

Learn More

About Bionest

We help clients navigate complex product development and commercialization issues in order to drive growth, create value and gain competitive advantage. We also offer our expertise and analytic skills to support investors with due diligence assignments. Our deep content experience, combined with our collaborative and hands-on approach results in practical solutions that drive internal alignment at the corporate, portfolio, and brand levels.